Regulation of ornithine decarboxylase during oncogenic transformation: Mechanisms and therapeutic potential

Amino Acids

Volumn 33, Issue 2, 2007, Pages 213-223

  Shantz, L M ^a   Levin, V A ^b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

DFMO; Oncogenic transformation; Ornithine decarboxylase; Polyamines

Indexed keywords

5' [(4 AMINO 2 BUTENYL)METHYLAMINO] 5' DEOXYADENOSINE; ALPHA INTERFERON; BETA INTERFERON; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DEXAMETHASONE; DOXORUBICIN; EFLORNITHINE; FLUOROURACIL; GAMMA INTERFERON; LOMUSTINE; MITOGUAZONE; NITROSOUREA; ORNITHINE DECARBOXYLASE; POLYAMINE; PROCARBAZINE; RETINOIC ACID; SAM 486A; UNCLASSIFIED DRUG; VINCRISTINE; VINDESINE;

AFRICAN TRYPANOSOMIASIS; ANTINEOPLASTIC ACTIVITY; BARRETT ESOPHAGUS; BIOSYNTHESIS; BLADDER CANCER; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER PREVENTION; CARCINOGENESIS; CARCINOGENICITY; CELL GROWTH; CELL TRANSFORMATION; CLINICAL TRIAL; COLON CANCER; COLORECTAL CANCER; COMBINATION CHEMOTHERAPY; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; ENZYME SYNTHESIS; HUMAN; IN VITRO STUDY; LEUKEMIA; LOW DRUG DOSE; LUNG NON SMALL CELL CANCER; MALIGNANT TRANSFORMATION; MELANOMA; MOLECULAR MECHANICS; NONHUMAN; ONCOGENE MYC; ONCOGENE RAS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DEGRADATION; REVIEW; SKIN CANCER; SKIN CARCINOGENESIS; TRACHEA CARCINOMA; TRANSCRIPTION INITIATION; TUMOR GROWTH; UNSPECIFIED SIDE EFFECT; UTERINE CERVIX CANCER;

ADENOSYLMETHIONINE DECARBOXYLASE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DRUG THERAPY, COMBINATION; EFLORNITHINE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAP KINASE KINASE KINASES; ORNITHINE DECARBOXYLASE; PROTEINS; SKIN NEOPLASMS;

ANIMALIA;

EID: 34547669262     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-007-0531-2     Document Type: Review

References (71)

1. MD Abeloff ST Rosen GD Luk SB Baylin M Zeltzman A Sjoerdsma 1986 Phase II trials of alpha-difluoromethylornithine, an inhibitor of polyamine synthesis, in advanced small cell lung cancer and colon cancer Cancer Treat Rep 70 843 845
2. M Auvinen A Paasinen LA Andersson E Hölttä 1992 Ornithine decarboxylase activity is critical for cell transformation Nature 360 355 358
3. J Bartholeyns 1983 Treatment of metastatic Lewis lung carcinoma with DL-alpha-difluoromethylornithine Eur J Cancer Clin Oncol 19 567 572
4. J Bartholeyns J Koch-Weser 1981 Effects of alpha-difluoromethylornithine alone and combined with doxorubicin or vindesine on L1210 leukemia in mice, EMT6 solid tumors in mice and solid tumors induced by injection of hepatoma tissue culture cells in rats J Cancer Res 41 5158 5161
5. MD Bregman FL Meyskens Jr 1986 Difluoromethylornithine enhances inhibition of melanoma cell growth in soft agar by dexamethasone, clone A interferon and retinoic acid Int J Cancer 37 101 107
6. L Carvalho K Foulkes DD Mickey 1989 Effect of DMSO and DFMO on rat prostate tumor growth Prostate 15 123 133
7. BK Chang O Black R Gutman 1984 Inhibition of growth of human or hamster pancreatic cancer cell lines by alpha-difluoromethylornithine alone and combined with cis-diamminedichloroplatinum(II) Cancer Res 44 5100 5104
8. BK Chang R Gutman TC Chou 1987 Schedule-dependent interaction of alpha-difluoromethylornithine and cis-diamminedichloroplatinum(II) against human and hamster pancreatic cancer cell lines Cancer Res 47 2247 2250
9. AR Cohen DD Pietronigro H Cravioto ES Flamm 1986 Effect of difluoromethylornithine on the antiglioma therapeutic efficacy of intra-arterial BCNU J Neurosurg 65 671 678
10. ET Creagan DJ Schaid DL Ahmann S Frytak 1990 Disseminated malignant melanoma and recombinant interferon: analysis of seven consecutive phase II investigations J Invest Dermatol 95 188S 192S
11. J Downward 2003 Targeting RAS signalling pathways in cancer therapy Nat Rev Cancer 3 11 22
12. RI Ernestus G Rohn R Schroder T Els A Klekner W Paschen N Klug 2001 Polyamine metabolism in brain tumours: diagnostic relevance of quantitative biochemistry J Neurol Neurosurg Psychiatry 71 88 92
13. DJ Feith DK Bol J Carboni M Lynch S Sass-Kuhn P Shoop LM Shantz 2005 Induction of ornithine decarboxylase activity is a necessary step for MEK-induced skin tumorigenesis Cancer Res 65 572 578
14. DJ Feith S Origanti PL Shoop S Sass-Kuhn LM Shantz 2006 Tumor suppressor activity of ODC antizyme in MEK-driven skin tumorigenesis Carcinogenesis 27 1090 1098
15. LY Fong DJ Feith AE Pegg 2003 Antizyme overexpression in transgenic mice reduces cell proliferation, increases apoptosis, and reduces N-nitrosomethylbenzylamine-induced forestomach carcinogenesis Cancer Res 63 3945 3954
16. JO Fredlund MC Johansson E Dahlberg SM Oredsson 1995 Ornithine decarboxylase and S-adenosylmethionine decarboxylase expression during the cell cycle of Chinese hamster ovary cells Exp Cell Res 216 86 92
17. Garewal HS, Sampliner RE, Fennerty MB (1992) Chemopreventive studies in Barrett's esophagus: a model premalignant lesion for esophageal adenocarcinoma. J Natl Cancer Inst Monographs: 51-54
18. EW Gerner FL Meyskens Jr 2004 Polyamines and cancer: old molecules, new understanding Nat Rev Cancer 4 781 792
19. K Gohji S Murao S Maeda T Sugiyama S Kamidono 1986 Enhanced inhibition of colony formation of human renal cell carcinoma in soft agar by the combination of alpha-difluoromethylornithine and recombinant gamma-interferon Cancer Res 46 6264 6268
20. Y Guo JL Cleveland TG O'Brien 2005 Haploinsufficiency for odc modifies mouse skin tumor susceptibility Cancer Res 65 1146 1149
21. Y Guo RB Harris D Rosson D Boorman TG O'Brien 2000 Functional analysis of human ornithine decarboxylase alleles Cancer Res 60 6314 6317
22. S Gupta N Ahmad SR Marengo GT MacLennan NM Greenberg H Mukhtar 2000 Chemoprevention of prostate carcinogenesis by α-difluoromethylorntihine in TRAMP mice Cancer Res 60 5125 5133
23. CS Hayes K Defeo L Lan B Paul C Sell SK Gilmour 2006 Elevated levels of ornithine decarboxylase cooperate with Raf/ERK activation to convert normal keratinocytes into invasive malignant cells Oncogene 25 1543 1553
24. M Herzig G Christofori 2002 Recent advances in cancer research: mouse models of tumorigenesis Biochim Biophys Acta 1602 97 113
25. E Hölttä L Sistonen K Alitalo 1988 The mechanism of ornithine decarboxylase deregulation in c-Ha-ras oncogene-transformed NIH 3T3 cells J Biol Chem 263 4500 4507
26. KJ Hunter DF Deen M Pellarin LJ Marton 1990 Effect of alpha-difluoromethylornithine on 1,3-bis(2-chloroethyl)-1-nitrosourea and cis-diamminedichloroplatinum(ii) cytotoxicity, DNA interstrand cross-linking, and growth in human brain tumor cell lines in vitro Cancer Res 50 2769 2772
27. NA Ignatenko N Babbar D Mehta RA Casero Jr EW Gerner 2004 Suppression of polyamine catabolism by activated Ki-ras in human colon cancer cells Mol Carcinog 39 91 102
28. AN Kingsnorth WE Russell PP McCann KA Diekema RA Malt 1983 Effects of alpha-difluoromethylornithine and 5-fluorouracil on the proliferation of a human colon adenocarcinoma cell line Cancer Res 43 4035 4038
29. S Klein JJ Miret ID Algranati ES de Lustig 1985 Effect of alpha-difluoromethylornithine in lung metastases before and after surgery of primary adenocarcinoma tumors in mice Biol Cell 53 33 36
30. DL Kramer BD Chang Y Chen P Diegelman K Alm AR Black IB Roninson CW Porter 2001 Polyamine depletion in human melanoma cells leads to G1 arrest associated with induction of p21WAF1/CIP1/SDI1, changes in the expression of p21-regulated genes, and a senescence-like phenotype Cancer Res 61 7754 7762
31. L Lan C Trempus SK Gilmour 2000 Inhibition of ornithine decarboxylase (ODC) decreases tumor vascularization and reverses spontaneous tumors in ODC/Ras transgenic mice Cancer Res 60 5696 5703
32. A Lazaris-Karatzas MR Smith RM Fredrickson ML Jaramillo Y Liu H Kung N Sonenberg 1992 Ras mediates translation initiation factor 4E-induced malignant transformation Genes Dev 6 1631 1642
33. VA Levin MC Chamberlain MD Prados AK Choucair MS Berger P Silver M Seager PH Gutin RL Davis CB Wilson 1987 Phase I-II study of eflornithine and mitoguazone combined in the treatment of recurrent primary brain tumors Cancer Treat Rep 71 459 464
34. VA Levin KR Hess A Choucair PJ Flynn KA Jaeckle AP Kyritsis WK Yung MD Prados JM Bruner S Ictech MJ Gleason HW Kim 2003 Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas Clin Cancer Res 9 981 990
35. VA Levin JL Jochec LM Shantz PE Koch AE Pegg 2004 Tissue-based assay for ornithine decarboxylase to identify patients likely to respond to difluoromethylornithine J Histochem Cytochem 52 1467 1474
36. L Li J Li JN Rao M Li BL Bass JY Wang 1999 Inhibition of polyamine synthesis induces p53 gene expression but not apoptosis Am J Physiol 276 C946 C954
37. GD Luk G Goodwin AF Gazdar SB Baylin 1982 Growth-inhibitory effects of DL-alpha-difluoromethylornithine in the spectrum of human lung carcinoma cells in culture Cancer Res 42 3070 3073
38. A Manni S Washington X Hu JW Griffith R Bruggeman LM Demers D Mauger MF Verderame 2005 Effects of polyamine synthesis inhibitors on primary tumor features and metastatic capacity of human breast cancer cells Clin Exp Metastasis 22 255 263
39. ME Martinez TG O'Brien KE Fultz N Babbar H Yerushalmi N Qu Y Guo D Boorman J Einspahr DS Alberts EW Gerner 2003 Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene Proc Natl Acad Sci USA 100 7859 7864
40. LJ Marton VA Levin SJ Hervatin J Koch-Weser PP McCann A Sjoerdsma 1981 Potentiation of the antitumor therapeutic effects of 1,3-bis(2-chloroethyl)-1- nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor Cancer Res 41 4426 4431
41. FL Meyskens EM Kingsley T Glattke L Loescher A Booth 1986 A phase II study of alpha-difluoromethylornithine (DFMO) for the treatment of metastatic melanoma Invest New Drugs 4 257 262
42. JP Moulinoux F Darcel V Quemener R Havouis N Seiler 1991 Inhibition of the growth of U-251 human glioblastoma in nude mice by polyamine deprivation Anticancer Res 11 175 179
43. JA Nilsson UB Keller TA Baudino C Yang S Norton JA Old LM Nilsson G Neale DL Kramer CW Porter JL Cleveland 2005 Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation Cancer Cell 7 433 444
44. TG O'Brien 1976 The induction of ornithine decarboxylase is an early, possibly obligatory event in mouse skin carcinogenesis Cancer Res 36 2644 2653
45. JA O'Shaughnessy LM Demers SE Jones J Arseneau P Khandelwal T George R Gersh D Mauger A Manni 1999 Alpha-difluoromethylornithine as treatment for metastatic breast cancer patients Clin Cancer Res 5 3438 3444
46. G Packham JL Cleveland 1994 Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis Mol Cell Biol 14 5741 5747
47. AE Pegg 2006 Regulation of ornithine decarboxylase J Biol Chem 281 14529 14532
48. A Peralta Soler G Gilliard L Megosh K George TG O'Brien 1998 Polyamines regulate expression of the neoplastic phenotype in mouse skin Cancer Res 58 1654 1659
49. J Perez-Losada A Balmain 2003 Stem-cell hierarchy in skin cancer Nature Rev Cancer 3 434 443
50. NJ Prakash PJ Schechter PS Mamont J Grove J Koch-Weser A Sjoerdsma 1980 Inhibition of EMT6 tumor growth by intereference with polyamine biosynthesis: effects of a-difluoromethlyornithine, an irreversible inhibitor of ornithine decarboxylase Life Sci 26 181 194
51. S Pyronnet A-C Gingras M Bouisson A Kowalski-Chauvel C Seva N Vaysse N Sonenberg L Pradayrol 1998 Gastrin induces phosphorylation of eIF4E binding protein 1 and translation initiation of ornithine decarboxylase mRNA Oncogene 16 2219 2227
52. S Pyronnet L Pradayrol N Sonenberg 2000 A cell cycle-dependent internal ribosome entry site Mol Cell 5 607 616
53. TA Ratko CJ Detrisac KV Rao CF Thomas GJ Kelloff RC Moon 1990 Interspecies analysis of the chemopreventive efficacy of dietary alpha-difluoromethylornithine Anticancer Res 10 67 72
54. MM Richert PA Phadke G Matters DJ DiGirolamo S Washington LM Demers JS Bond A Manni DR Welch 2005 Metastasis of hormone-independent breast cancer to lung and bone is decreased by alpha-difluoromethylornithine treatment Breast Cancer Res 7 R819 R827
55. D Rousseau R Kaspar I Rosenwald L Gehrke N Sonenberg 1996 Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E Proc Natl Acad Sci USA 93 1065 1070
56. G Scalabrino ME Ferioli 1985 Degree of enhancement of polyamine biosynthetic decarboxylase activities in human tumors: a useful new index of degree of malignancy Cancer Detect Prev 8 11 16
57. ER Seidel VL Ragan 1997 Inhibition by rapamycin of ornithine decarboxylase and epithelial cell proliferation in intestinal IEC-6 cells in culture Br J Pharmacol 120 571 574
58. LM Shantz 2004 Transcriptional and translational control of ornithine decarboxylase during Ras transformation Biochem J 377 257 264
59. LM Shantz AE Pegg 1994 Overproduction of ornithine decarboxylase caused by relief of translational repression is associated with neoplastic transformation Cancer Res 54 2313 2316
60. LM Shantz AE Pegg 1998 Ornithine decarboxylase induction in transformation by H-Ras and RhoA Cancer Res 58 2748 2753
61. LM Shantz AE Pegg 1999 Translational regulation of ornithine decarboxylase and other enzymes of the polyamine pathway Int J Biochem Cell Biol 31 107 122
62. M Stoneley AE Willis 2004 Cellular internal ribosome entry segments: structures, trans-acting factors and regulation of gene expression Oncogene 23 3200 3207
63. P Sunkara A Rosenberger 1987 Antimetastatic activity of DL-alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, in mice Cancer Res 47 933 935
64. PS Sunkara TL Bowlin AL Rosenberger 1989 Effect of murine alpha, beta and gamma interferons in combination with alpha-difluoromethyl-ornithine, an inhibitor of polyamine biosynthesis, on the tumor growth and metastasis of B16 melanoma and Lewis lung carcinoma in mice J Biol Response Mod 8 170 179
65. PS Sunkara NJ Prakash GD Mayer A Sjoerdsma 1983 Tumor suppression with a combination of alpha-difluoromethyl ornithine and interferon Science 219 851 853
66. M Talpaz C Plager J Quesada R Benjamin H Kantarjian J Gutterman 1986 Difluoromethylornithine and leukocyte interferon: a phase I study in cancer patients Eur J Cancer Clin Oncol 22 685 689
67. A Tamori S Nishiguchi T Kuroki N Koh K Kobayashi Y Yano S Otani 1995 Point mutation of ornithine decarboxylase gene in human hepatocellular carcinoma Cancer Res 55 3500 3503
68. ± mice J Clin Invest 113 867 875
69. CJ Wallick I Gamper M Thorne DJ Feith KY Takasaki SM Wilson JA Seki AE Pegg CV Byus AS Bachmann 2005 Key role for p27Kip1, retinoblastoma protein Rb, and MYCN in polyamine inhibitor-induced G1 cell cycle arrest in MYCN-amplified human neuroblastoma cells Oncogene 24 5606 5618
70. DL Wheeler KJ Ness TD Oberley AK Verma 2003 Inhibition of development of metastatic squamous cell carcinoma in protein kinase C ε transgenic mice by α-difluoromethylornithine accompanied by marked hair follicle degeneration and hair loss Cancer Res 63 3037 3042
71. HF Yerushalmi DG Besselsen NA Ignatenko KA Blohm-Mangone JL Padilla-Torres DE Stringer JM Guillen H Holubec CM Payne EW Gerner 2006 Role of polyamines in arginine-dependent colon carcinogenesis in Apc(Min) (/+) mice Mol Carcinog 45 764 773